Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Am J Transplant. 2019 Dec 24;20(4):1028–1038. doi: 10.1111/ajt.15687

Figure 2: Freedom from donor-specific antibodies (DSA) after lung transplantation (LTx).

Figure 2:

Kaplan-Meier survival methods estimated the proportion of recipients in whom DSA had not occurred at follow-up after lung transplantation (LTx). The numbers below the x-axis time points represent those at risk. Cohorts consisted of primary LTx reported from January 1, 2008 and December 31, 2015, with follow-up through December 31, 2018. Analyses censored for end of study follow-up and loss to follow-up.